SCFAs & Satiety Receptors: FFAR2 & FFAR3 Acetate/Propionate/Butyrate

The Chemical Vocabulary of the Microbiome-Gut-Brain Axis
For centuries, medicine viewed the human colon primarily as a sewage processing organ designed to absorb water and eliminate solid waste. Today, we know that the human colon is an ultra-dense, metabolic chemical reactor hosting over 100 trillion symbiotic microorganisms.When dietary prebiotic fibers and resistant starches reach these anaerobic microbes, they are fermented into three microscopic, carbon-chain molecules that function as the master chemical messengers of systemic human metabolism: The Short-Chain Fatty Acids (SCFAs):
- Acetate ($C2$): The most abundant SCFA ($~60\%$), which crosses into systemic circulation to modulate peripheral adipose tissue and cross the blood-brain barrier.
- Propionate ($C3$): ($~20\%$), which is cleared by the liver via portal blood, potently inhibiting hepatic gluconeogenesis and de novo lipogenesis.
- Butyrate ($C4$): ($~20\%$), the primary energy currency consumed by colonocytes to power epithelial renewal.
In modern molecular endocrinology, the discovery that humans possess specialized cell-surface receptors evolved specifically to "taste" and respond to these microbial SCFAs transformed our understanding of appetite: Free Fatty Acid Receptor 2 (FFAR2 / GPR43) and Free Fatty Acid Receptor 3 (FFAR3 / GPR41)!
Receptor Spectrum: FFAR2 vs. FFAR3 Molecular Biophysics
| Receptor Name | G-Protein Coupling | SCFA Ligand Affinity Hierarchy | Tissue Localization | Primary Metabolic Consequence |
|---|---|---|---|---|
| FFAR2 (GPR43) | Dual $G{i/o}$ and $Gq$ | Acetate ($C2$) = Propionate ($C3$) $>$ Butyrate ($C4$) | Colonic L-cells, adipocytes, immune cells | Surges GLP-1/PYY exocytosis; shuts off adipocyte lipolysis |
| FFAR3 (GPR41) | Primarily $G{i/o}$ | Propionate ($C3$) $\ge$ Butyrate ($C4$) $>$ Acetate ($C2$) | Enteroendocrine cells, autonomic nerves | Activates sympathetic energy expenditure & vagal tone |
| Vagal Sensory Afferents | Direct chemoreception | High affinity for portal acetate & propionate | Nodose Ganglion terminals | Directly silences orexigenic NPY/AgRP hunger neurons! |
| Central Hypothalamus | Direct crossing of BBB | Acetate crosses BBB into arcuate nucleus | POMC/CART neurons | Suppresses central appetite independently of hormones! |
[Anaerobic Fermentation of Prebiotic Fibers in the Cecum & Colon]
โ
โผ
[Generates High Concentrations of Luminal SCFAs: Acetate (C2), Propionate (C3), Butyrate (C4)]
โ
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโฌโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ
โผ โผ โผ
[BINDS FFAR2 (GPR43) ON L-CELLS] [BINDS FFAR3 (GPR41) ON L-CELLS] [SYSTEMIC PORTAL ABSORPTION]
โ โ โ
โผ โผ โผ
[Gq-Mediated Phospholipase C] [Gi-Mediated Signaling] [Propionate Enters Portal Vein]
โ โ โ
โผ โผ โผ
[Intracellular Calcium ($Ca^{2+}$) Influx into Enteroendocrine L-Cells] [Inhibits Hepatic Glucose Output]
โ โ โ
โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโดโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโค
โผ โผ
[MASSIVE CO-EXOCYTOSIS OF GLP-1 & PEPTIDE YY (PYY) INTO BLOODSTREAM] [Acetate Crosses Blood-Brain Barrier]
โ โ
โผ โผ
[Crosses into Arcuate Nucleus of the Hypothalamus] [Activates Hypothalamic Acetyl-CoA]
โ โ
โโโบ [Potently Inhibits Orexigenic Neuropeptide Y (NPY) Neurons] โ
โ โ
โโโบ [Fires Anorexigenic Pro-opiomelanocortin (POMC) Neurons] โโโโโโโโ
โ
โโโบ [Completely Extinguishes Metabolic Hunger, Driving Deep Whole-Body Satiation!]
Pharmacological Actions in Hypothalamic Appetite & Gut Motility
- The Landmark Human Inulin-Propionate Ester Trials: In double-blind, randomized, placebo-controlled clinical trials published in the journal Gut (Chambers et al., Imperial College London), delivering propionate specifically to the human colon via inulin-propionate ester statistically significantly stimulated a 50% increase in post-prandial PYY and GLP-1 release, reduced spontaneous buffet caloric intake by 14%, and completely prevented long-term body weight and abdominal visceral fat gain over 24 weeks!
- Central Hypothalamic Acetate PET-Scan Proof: Contemporary neuroimaging published in Nature Communications (Frost et al.) demonstrated via carbon-11 PET scanning that colonic acetate crosses the human blood-brain barrier, directly accumulating in the hypothalamus where it alters neurotransmitter profiles to switch off feeding behavior.
The Master "Multi-Substrate SCFA" Fermentation Protocol

[!IMPORTANT]
Feed ALL Three SCFA Pathways with Multi-Fiber Diversity!
Feeding only one fiber type produces only one SCFA. To trigger both FFAR2 and FFAR3 receptors simultaneously, consume a diverse matrix: Inulin (for acetate), Beta-Glucans (for propionate), and Resistant Starch (for butyrate)!
- The Clinical Multi-SCFA Prebiotic Daily Target:
Safety & Fermentation Titration
- Titrate Slowly: Individuals with Irritable Bowel Syndrome (IBS) or Small Intestinal Bacterial Overgrowth (SIBO) should introduce fermentable prebiotic substrates slowly to avoid excess proximal gas production.
Interactive Longevity Tools & Related Protocols
- ๐ฅฆ Balance your prebiotic macro targets with the Macro Calculator.
- ๐ง Support colonic hydration and microbial biomass with the Hydration Calculator.
Primary Scientific Citations
- Chambers, E. S., et al. (2015). Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut, 64(11), 1744-1754.
- Frost, G., et al. (2014). The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications, 5, 3611.
๐ฌ Reader Reflections & Discussions (0)
Leave a Reflection / Botanical Question